
ASLAN Pharmaceuticals Limited ASLN
Geschäftsbericht 2020
hinzugefügt 19.08.2023
ASLAN Pharmaceuticals Limited Langfristiger Schuldenstrom 2011-2026 | ASLN
Langfristiger Schuldenstrom Jährlich ASLAN Pharmaceuticals Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 272 K | 265 K | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 272 K | 265 K | 268 K |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
AbCellera Biologics
ABCL
|
5.82 M | $ 3.64 | -1.89 % | $ 1.09 B | ||
|
ADMA Biologics
ADMA
|
1.1 M | $ 16.45 | 0.43 % | $ 3.92 B | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
ANI Pharmaceuticals
ANIP
|
1.8 M | $ 76.75 | 0.85 % | $ 1.48 B | ||
|
Apellis Pharmaceuticals
APLS
|
7.09 M | $ 19.93 | -1.14 % | $ 2.51 B | ||
|
Acer Therapeutics
ACER
|
104 K | - | 2.71 % | $ 14 M | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
Aptorum Group Limited
APM
|
433 K | $ 0.83 | 4.23 % | $ 4.53 M | ||
|
Athersys
ATHX
|
1.01 M | - | 3.77 % | $ 22.4 M | ||
|
AVEO Pharmaceuticals
AVEO
|
11 K | - | - | $ 521 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
549 K | - | -2.5 % | $ 5.88 M | ||
|
Axsome Therapeutics
AXSM
|
434 K | $ 163.82 | -0.14 % | $ 8.15 B | ||
|
Adverum Biotechnologies
ADVM
|
5.67 M | - | - | $ 86.2 M | ||
|
BridgeBio Pharma
BBIO
|
6.19 M | $ 66.98 | 3.8 % | $ 12.8 B | ||
|
CymaBay Therapeutics
CBAY
|
7 K | - | - | $ 3.45 B | ||
|
Avid Bioservices
CDMO
|
1.35 M | - | - | $ 789 M | ||
|
ARCA biopharma
ABIO
|
213 K | - | 1052.0 % | $ 415 M | ||
|
Caladrius Biosciences
CLBS
|
137 K | - | -16.75 % | $ 25.8 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
BioLineRx Ltd.
BLRX
|
522 K | $ 2.88 | 2.51 % | $ 908 M | ||
|
Acorda Therapeutics
ACOR
|
1.59 M | - | -24.86 % | $ 820 K | ||
|
BioMarin Pharmaceutical
BMRN
|
8.57 M | $ 60.75 | 3.79 % | $ 11.7 B | ||
|
Acasti Pharma
ACST
|
75 K | - | 4.01 % | $ 150 M | ||
|
CTI BioPharma Corp.
CTIC
|
781 K | - | - | $ 1.2 B | ||
|
Deciphera Pharmaceuticals
DCPH
|
3.5 M | - | - | $ 2.18 B | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Aeterna Zentaris
AEZS
|
271 K | - | 5.93 % | $ 314 M | ||
|
Cabaletta Bio
CABA
|
3.56 M | $ 3.41 | 4.77 % | $ 3.98 M | ||
|
Capricor Therapeutics
CAPR
|
749 K | $ 25.71 | -0.5 % | $ 688 M | ||
|
AgeX Therapeutics
AGE
|
428 K | - | -10.17 % | $ 12.2 K | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
Codexis
CDXS
|
2.83 M | $ 1.1 | 12.24 % | $ 80.7 M | ||
|
Certara
CERT
|
3.92 M | $ 7.33 | 1.24 % | $ 1.18 B | ||
|
Entasis Therapeutics Holdings
ETTX
|
704 K | - | - | $ 105 M | ||
|
Evofem Biosciences
EVFM
|
97 K | - | 7.55 % | $ 38.1 M |